Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia.
Carlotta Caia, Francesca De Maria, Francesco Sopracordevole...
https://pubmed.ncbi.nlm.nih.gov/40277212Actively Recruiting
Age: 18Years +
FEMALE
Healthy Volunteers
ID06611020
The Role of Adjuvant VaccInation After Conization for the Treatment for Cervical Dysplasia
Led by Fondazione IRCCS Istituto Nazionale dei Tumori, Milano · Updated on 2024-09-26
600
Participants Needed
2
Research Sites
104 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
HPV vaccination has emerged as a strategy to reduce the risk of recurrence oafter excisional treatment. However, only few data are aviable. In this trial the investigators aim to assess the role of HPV vaccination in women traeted for HPV-related lesions
CONDITIONS
Brief Title
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
Who Can Participate
Age: 18Years +
FEMALE
Healthy Volunteers
Eligibility Criteria
You may qualify if you...
- Treatment of HPV-related disease
You will not qualify if you...
- Previous HPV vaccination
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
1
2
3
Trial Site Locations
Total: 2 locations
1
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy, 20148
Actively Recruiting
2
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Lombardy, Italy, 20148
Actively Recruiting
Loading map...
Research Team
G
Giorgio Bogani, ph.d.
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Similar Trials
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here